Market Overview

D.A. Davidson Reiterates Buy Rating, $72 PT on Herbalife Ltd.

Share:
Related HLF
Benzinga's Weekend M&A Chatter
Herbalife Spikes Up Amid Report That Bill Stiritz Has Increased His Stake
Rite Aid's (RAD) Key Sales Metrics for January Rise 4.8% - Analyst Blog (Zacks)

In a report published Friday, D.A. Davidson & Co. reiterated its Buy rating and $72.00 price target on Herbalife Ltd. (NYSE: HLF).

D.A. Davidson noted, “We were attentive to the 210-minute presentation launched today by Bill Ackman, of Pershing Square, who is short Herbalife shares and describes himself as being the majority of the 20.7 million shares sold short. That would put the short bet in the $400 million-plus range – certainly not insignificant – and, in his words, only his second large short position of his life. Mr. Ackman, if nothing else, did an enormous amount of work on this short idea and presented it in a very organized way. The central thesis of Ackman's claim is that Herbalife is a fraudulent and illegal pyramid scheme. There are dozens of slides that are used to support the claim, but the central thesis seems to be that the compensation in royalties and overrides paid to the top distributors – which are very clearly linked to a volume point of product sales – is actually a payment for recruiting. We disagree and we suspect the company has multiple logical arguments should it ever need to defend itself to regulators.”

Herbalife Ltd. closed on Thursday at $33.70.

Latest Ratings for HLF

DateFirmActionFromTo
Jan 2015BarclaysMaintainsOverweight
Jan 2015Buckingham ResearchDowngradesBuyNeutral
Nov 2014BarclaysMaintainsOverweight

View More Analyst Ratings for HLF
View the Latest Analyst Ratings

Posted-In: D.A. Davidson & Co.Analyst Color Reiteration Analyst Ratings

 

Related Articles (HLF)

Around the Web, We're Loving...

Get Benzinga's Newsletters